Biovica International (Sweden) Performance
| BIOVIC-B | SEK 2.30 0.01 0.43% |
The firm shows a Beta (market volatility) of 0.47, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Biovica International's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biovica International is expected to be smaller as well. At this point, Biovica International has a negative expected return of -0.12%. Please make sure to confirm Biovica International's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Biovica International performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Biovica International AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
| Begin Period Cash Flow | 145.4 M | |
| Total Cashflows From Investing Activities | -3.4 M |
Biovica |
Biovica International Relative Risk vs. Return Landscape
If you would invest 267.00 in Biovica International AB on September 3, 2024 and sell it today you would lose (37.00) from holding Biovica International AB or give up 13.86% of portfolio value over 90 days. Biovica International AB is generating negative expected returns and assumes 4.6678% volatility on return distribution over the 90 days horizon. Simply put, 41% of stocks are less volatile than Biovica, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Biovica International Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biovica International's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biovica International AB, and traders can use it to determine the average amount a Biovica International's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0266
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BIOVIC-B |
Estimated Market Risk
| 4.67 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Biovica International is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biovica International by adding Biovica International to a well-diversified portfolio.
Biovica International Fundamentals Growth
Biovica Stock prices reflect investors' perceptions of the future prospects and financial health of Biovica International, and Biovica International fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biovica Stock performance.
| Return On Equity | -0.65 | |||
| Return On Asset | -0.36 | |||
| Operating Margin | (14.77) % | |||
| Current Valuation | 175.91 M | |||
| Shares Outstanding | 39.47 M | |||
| Price To Book | 2.26 X | |||
| Price To Sales | 48.31 X | |||
| Revenue | 2.04 M | |||
| EBITDA | (75.36 M) | |||
| Cash And Equivalents | 89.79 M | |||
| Cash Per Share | 0.71 X | |||
| Total Debt | 8.78 M | |||
| Book Value Per Share | 2.86 X | |||
| Cash Flow From Operations | (52.13 M) | |||
| Earnings Per Share | (2.11) X | |||
| Total Asset | 151.63 M | |||
About Biovica International Performance
By analyzing Biovica International's fundamental ratios, stakeholders can gain valuable insights into Biovica International's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biovica International has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biovica International has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Biovica International AB , a biotech company, develops and commercializes blood-based biomarker assays that enhance the monitoring of cancer therapies and predict patient outcome. Biovica International AB was founded in 2009 and is based in Uppsala, Sweden. Biovica International operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 17 people.Things to note about Biovica International performance evaluation
Checking the ongoing alerts about Biovica International for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biovica International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biovica International generated a negative expected return over the last 90 days | |
| Biovica International has high historical volatility and very poor performance | |
| The company reported the revenue of 2.04 M. Net Loss for the year was (60 M) with profit before overhead, payroll, taxes, and interest of 4.73 M. | |
| Biovica International AB has accumulated about 89.79 M in cash with (52.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71. |
- Analyzing Biovica International's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biovica International's stock is overvalued or undervalued compared to its peers.
- Examining Biovica International's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biovica International's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biovica International's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biovica International's stock. These opinions can provide insight into Biovica International's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Biovica Stock analysis
When running Biovica International's price analysis, check to measure Biovica International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovica International is operating at the current time. Most of Biovica International's value examination focuses on studying past and present price action to predict the probability of Biovica International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovica International's price. Additionally, you may evaluate how the addition of Biovica International to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |